Tobramix 300 mg Inhalation Solution 5 ml
₹359.1*
MRP ₹399
10% off
₹339*
MRP ₹399
15% CB
₹60 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Tobramix 300 mg Inhalation Solution 5 ml belongs to the class of aminoglycoside antibiotics. Tobramix 300 mg Inhalation Solution 5 ml is used to treat chest infections caused by the bacteria Pseudomonas aeruginosa in cystic fibrosis patients aged six years and older. Pseudomonas aeruginosa is a type of bacteria that can cause lung or chest infections, especially in people who already have a lung disease (cystic fibrosis) or an issue with their immune system.
Tobramix 300 mg Inhalation Solution 5 ml contains Tobramycin, an aminoglycoside antibiotic that fights the infection in your lungs by interfering with protein synthesis in Pseudomonas bacterial cell and helps you breathe better.
Use the Tobramix 300 mg Inhalation Solution 5 ml as prescribed by your doctor. Sometimes, you may experience certain common side effects, such as runny or stuffy nose, sneezing, voice alteration (hoarseness), discolouration of the substance you cough up (sputum), worsening of lung function test results, feeling unwell, muscle pain and voice alteration with sore throat and difficulty swallowing (laryngitis). Most of these side effects do not require medical attention and resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not use Tobramix 300 mg Inhalation Solution 5 ml if you are allergic to any of its components or other aminoglycoside antibiotics. Do not use the Tobramix 300 mg Inhalation Solution 5 ml without consulting your doctor if you are pregnant or breastfeeding. Tell your doctor before prescribing Tobramix 300 mg Inhalation Solution 5 ml if you have hearing problems, kidney problems, unusual difficulty breathing with wheezing or coughing, chest tightness, blood in the sputum, muscle weakness, and Parkinson's disease. Tobramix 300 mg Inhalation Solution 5 ml is not recommended to be used in children under the age of six.
Tobramix 300 mg Inhalation Solution 5 ml contains Tobramycin, an aminoglycoside antibiotic that fights pulmonary infection by interfering with protein synthesis in Pseudomonas bacterial cells and allows you to breathe easier.
Do not use Tobramix 300 mg Inhalation Solution 5 ml if you are allergic to any of the components or other aminoglycoside antibiotics (neomycin, paromomycin, kanamycin). Do not use the Tobramix 300 mg Inhalation Solution 5 ml without consulting your doctor if you are pregnant or breastfeeding. Tell your doctor before prescribing Tobramix 300 mg Inhalation Solution 5 ml if you have hearing problems, kidney problems, unusual difficulty breathing with wheezing or coughing, chest tightness, blood in the sputum, muscle weakness, and Parkinson's disease. Children and adolescents aged six and up are eligible to use Tobramix 300 mg Inhalation Solution 5 ml. Tobramix 300 mg Inhalation Solution 5 ml should not be given to children under the age of six. Before taking the Tobramix 300 mg Inhalation Solution 5 ml, notify your doctor about your medical history and other medications you are now taking to rule out any potential adverse effects or interactions.
Drug-Drug interactions: Tobramix 300 mg Inhalation Solution 5 ml may interact with bronchodilators (e.g. salbutamol), diuretic medications (e.g. furosemide, ethacrynic acid) and medicines that lower pressure in the head (e.g. intravenous mannitol).
Drug-Food interactions: Relevant interactions could not be found/established.
Drug-Disease interactions: Inform your doctor if you have hearing problems, kidney or liver problems, chest tightness, blood in the sputum, dehydration, muscle disorders, poisoning caused by toxins, hypocalcaemia (levels of calcium in your blood are too low), diarrhoea, vomiting, myoneural disease (neuromuscular disorder) and unusual difficulty breathing with wheezing or coughing.
Pseudomonas aeruginosa infection: Pseudomonas aeruginosa is a type of bacteria that can cause lung or chest infections, especially in people who already have a lung disease (cystic fibrosis) or an issue with their immune system.
Cystic fibrosis: Cystic fibrosis is a hereditary disease that affects the digestive system and lungs. In this condition, the body produces a thick, sticky fluid that obstructs the pancreas and clogs the lungs.
Alcohol
Caution
It is unknown if alcohol affects Tobramix 300 mg Inhalation Solution 5 ml. However, it is advisable to limit or avoid alcohol as a precautionary measure.
Pregnancy
Caution
Tobramix 300 mg Inhalation Solution 5 ml may not be recommended to be used in pregnancy. If you are pregnant, please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Consult your doctor as there is no substantial research yet on using Tobramix 300 mg Inhalation Solution 5 ml in breastfeeding/nursing mothers.
Driving
Safe if prescribed
Tobramix 300 mg Inhalation Solution 5 ml may not affect your ability to drive, use, or operate machines.
Liver
Caution
Limited information about the usage of Tobramix 300 mg Inhalation Solution 5 ml in patients with liver disease is available. Please consult your physician. Your doctor will weigh the benefits and potential risks before prescribing Tobramix 300 mg Inhalation Solution 5 ml.
Kidney
Caution
Limited information about the usage of Tobramix 300 mg Inhalation Solution 5 ml in patients with kidney disease is available. Please consult your physician. Your doctor will weigh the benefits and potential risks before prescribing Tobramix 300 mg Inhalation Solution 5 ml.
Children
Caution
Children and adolescents aged six and up are eligible to use Tobramix 300 mg Inhalation Solution 5 ml. Tobramix 300 mg Inhalation Solution 5 ml should not be given to children under the age of six.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes